肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

王真; 徐增辉; 郑罗凝; 王颖; 孙保木; 金华君; 钱其军

doi:10.3969/j.issn.1006-0111.2015.02.018

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018

1.
东方肝胆外科医院病毒基因治疗实验室, 上海 200438;东方肝胆外科医院生物治疗科, 上海 200438
2.
东方肝胆外科医院病毒基因治疗实验室, 上海 200438
3.
浙江理工大学生命科学学院, 杭州 310018
4.
东方肝胆外科医院中西医结合科, 上海 200438
5.
东方肝胆外科医院病毒基因治疗实验室, 上海 200438;东方肝胆外科医院生物治疗科, 上海 200438;浙江理工大学生命科学学院, 杭州 310018

基金项目: 国家自然科学基金(No.81301307);国家传染病防治重大专项(No.2013ZX10002-010-007);上海细胞治疗工程技术研究中心科研基金(No.12DZ2251600);上海市卫生局科研基金(No.20114179)

Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma

1.
Laboratory of Gene and Viral Therapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China;Department of Biotherapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
2.
Laboratory of Gene and Viral Therapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
3.
College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, China
4.
Department of Integration of Traditional Chinese and Western medicine, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China
5.
Laboratory of Gene and Viral Therapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China;Department of Biotherapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China;College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, China

摘要: 目的研究肝细胞癌(hepatocellular carcinoma, HCC)患者外周血循环肿瘤细胞(circulating tumor cell, CTC)与肿瘤转移和预后的关系。方法选取35例肝细胞癌患者, 应用密度梯度离心法联合免疫磁珠阴性富集法富集CTC, 然后利用染色体荧光原位杂交和细胞免疫荧光技术进行CTC鉴定并计数, 同时记录临床相关特征, 对数据进行统计学分析。结果所有患者均检出CTC, 阳性率为100%, CTC个数均值为(4.1±2.5) 个。对患者进行分组, Ⅰ组的CTC个数<5, Ⅱ组的CTC数量≥5。Ⅰ组、Ⅱ组的CTC数量差异有统计学意义(P=0.001), 患者的性别、年龄与肿瘤转移无关(P=0.581、0.531), CTC的数量与转移及预后有关(P=0.024、0.01),Ⅰ组、Ⅱ组的转移和预后差异有统计学意义。结论 HCC患者外周血CTC的数量与肿瘤转移及预后有关,CTC的数量≥5时,可能肿瘤更具转移倾向,预后更差,患者生存期更短。
- 肝细胞癌 /
- 循环肿瘤细胞 /
- 转移 /
- 预后
Abstract: Objective To study the relationship between circulating tumor cells(CTCs) in peripheral blood of the patients with hepatocellular carcinoma (HCC) and its metastasis and prognosis. Methods 35 patients with hepatocellular carcinoma were collected as the research objects.CTCs density were enriched through gradient centrifugation and negative-immunomagnetic methods, then the cells were detected by chromosome fluorescence in situ hybridization combined with immunofluorescence tests to identify CTCs. The clinical characters were recorded and the data were statistically analyzed. Results All the patients were detected CTC positive. The number of CTC was (4.1±2.5).The patients were divided into 2 groups.Group Ⅰ included patients whose CTCs were <5,and others were included in group Ⅱ.The difference between number of group I and group Ⅱ had significant significance(P=0.001); Metastasis had nothing to do with patients' sex and age(P=0.581,0.531); The number of CTCs was related to metastasis and prognosis(P=0.024,0.01),and there was significant statistic significance between group I and group Ⅱ. Conclusion The number of CTCs was related to tumor metastasis.The tumor may be more prone to occur metastasis and may had worse prognosis,and the patients may had shorter life time when the number of CTCs was≥5.
- hepatocellular carcinoma /
- circulating tumor cell /
- metastasis /
- prognosis

[1]	Cha C, Fong Y, Jarnagin WR, et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma[J]. J Am Coll Surg, 2003, 197(5): 753-758.
[2]	Pantel K, Brakenhoff RH. Dissecting the metastatic cascade[J]. Nat Rev Cancer, 2004, 4(6): 448-456.
[3]	Shao C, Liao CP, Hu P, et al. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer[J]. PLoS One, 2014, 9(2): e88967.
[4]	Seeberg LT, Waage A, Brunborg C, et al. Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival[J]. Ann Surg, 2015, 261(1): 164-171.
[5]	Mikulova V, Cabinakova M, Janatkova I, et al. Detection of circulating tumor cells during follow-up of patients with early breast cancer: clinical utility for monitoring of therapy efficacy[J]. Scand J Clin Lab Invest, 2014, 74(2): 132-142.
[6]	Muinelo-Romay L, Vieito M, Abalo A, et al. Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment[J]. Cancers (Basel), 2014, 6(1): 153-165.
[7]	Poveda A, Kaye SB, McCormack R, et al. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer[J]. Gynecol Oncol, 2011, 122(3): 567-572.
[8]	Zigeuner RE, Riesenberg R, Pohla H, et al. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro[J]. J Urol, 2003, 169(2): 701-705.
[9]	Wu C, Hao H, Li L, et al. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients[J]. J Thorac Oncol, 2009, 4(1): 30-36.
[10]	Gisselsson D.Refined characterisation of chromosome aberrations in tumours by multicolour banding and electronic mapping resources[J].Methods Cell Sci,2001,23(1-3):23-28.
[11]	Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1869, 14(146-149.
[12]	Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition[J]. Science, 2013, 339(6119): 580-584.
[13]	Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis[J]. Cancer Cell, 2011, 20(5): 576-590.
[14]	曹宇勃,许崇安. 循环肿瘤细胞预测肝细胞癌患者临床预后价值的Meta分析[J]. 中国全科医学, 2014, 17(12): 1394-1399.
[15]	Sun YF, Xu Y, Yang XR, et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection[J]. Hepatology, 2013, 57(4): 1458-1468.

[1]	陈官旭, 宋雨桐, 郭秀强, 张咪, 刘志宏, 宋洪涛. EGFR-TKIs单药及其联合方案在晚期非小细胞肺癌一线治疗中的疗效与安全性比较：网状Meta分析 . 药学实践与服务, 2025, 43(): 1-11. doi: 10.12206/j.issn.2097-2024.202504044
[2]	李娜, 黄诚文, 孙秀娟, 王晓红, 张丽, 王兴坡. 奥希替尼与吉非替尼治疗表皮生长因子受体突变的晚期非小细胞肺癌的成本效果分析 . 药学实践与服务, 2025, 43(12): 608-613. doi: 10.12206/j.issn.2097-2024.202411032
[3]	曹奇, 张嘉宝, 王培. 基于无监督自动降维分析与手动圈门联用的骨骼肌髓系细胞多色流式分析方法 . 药学实践与服务, 2025, 43(7): 325-328, 366. doi: 10.12206/j.issn.2097-2024.202404077
[4]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架治疗创伤性脑损伤的研究 . 药学实践与服务, 2025, 43(2): 67-74. doi: 10.12206/j.issn.2097-2024.202406034
[5]	胡越, 殷勇, 徐晓红, 施柳辉, 朱建勇, 年华. 基于网络药理学探讨夏枯草消瘤合剂治疗非小细胞肺癌的作用机制 . 药学实践与服务, 2025, 43(12): 1-8. doi: 10.12206/j.issn.2097-2024.202302020
[6]	杨志晖, 蔡华丹, 徐方楚, 刘园, 袁海龙. 临床药师参与人粒细胞刺激因子致弥漫性肺泡出血的病例分析 . 药学实践与服务, 2025, 43(11): 567-571. doi: 10.12206/j.issn.2097-2024.202506021
[7]	孙波, 吕宗强, 罗宁, 李荣, 王洪祥, 陈菊祥. Angiopep-2修饰的细菌外囊泡载药系统治疗胶质母细胞瘤效果研究 . 药学实践与服务, 2025, 43(10): 481-490. doi: 10.12206/j.issn.2097-2024.202506017
[8]	于翔, 贾培培, 李欣颖, 杨君君, 郭高峰, 陆连芳. M2型巨噬细胞外泌体喷剂对压力性损伤的疗效及作用机制 . 药学实践与服务, 2025, 43(9): 436-442. doi: 10.12206/j.issn.2097-2024.202503066
[9]	赵全公, 王国坤, 徐志云. 虾青素通过激活Nrf2/HO-1通路抑制瓣膜间质细胞钙化 . 药学实践与服务, 2025, 43(6): 283-287. doi: 10.12206/j.issn.2097-2024.202412057
[10]	邵明聪, 陈虎博, 张懿丹, 李梓嫣, 王丽娜. 乌头煎剂对小鼠RAW264.7巨噬细胞活性和极化的影响 . 药学实践与服务, 2025, 43(7): 329-334. doi: 10.12206/j.issn.2097-2024.202505043
[11]	王鹏, 张争艳, 吴宗贵. 活心丸（浓缩丸）联合八段锦对急性心肌梗死合并心力衰竭介入术预后的影响 . 药学实践与服务, 2025, 43(7): 348-352. doi: 10.12206/j.issn.2097-2024.202308034
[12]	赵凤平, 于镇铭, 陈熹, 姜棋文, 郑灿辉, 陈新. 醛脱氢酶2改善铁死亡相关疾病预后的研究进展 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.202411043
[13]	杨金润, 黎翔, 孙旸. ORM1促肝细胞增殖的作用及其机制探索 . 药学实践与服务, 2025, 43(5): 222-227. doi: 10.12206/j.issn.2097-2024.202410014
[14]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[15]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[16]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[17]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
[18]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[19]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[20]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027

点击查看大图

计量

文章访问数: 6095
HTML全文浏览量: 421
PDF下载量: 678
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018

Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma

计量

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018

English Abstract

Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma

全文HTML

目录

留言板

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018

Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma

计量

出版历程

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018

English Abstract

Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma

全文HTML

目录